Stryker had three patents in cybersecurity during Q4 2023. Stryker Corp’s patent filed in Q4 2023 involves a method for optimizing medical treatment plans using kinematics data from wearable sensors. The method includes determining a treatment plan for installing an implant based on stored information from previous patients with similar characteristics. This innovation aims to improve the alignment, position, design, or type of implants for better patient outcomes. GlobalData’s report on Stryker gives a 360-degreee view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Premium Insights Stryker Corp - Company Profile

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

Stryker grant share with cybersecurity as a theme is 33% in Q4 2023. Grant share is based on the ratio of number of grants to total number of patents.

Recent Patents

Application: Devices, systems, and methods for optimizing medical procedures and outcomes (Patent ID: US20230377714A1)

The patent filed by Stryker Corp. discloses a method for optimizing a medical treatment plan by receiving kinematics data from a wearable sensor coupled to a patient, determining a treatment plan based on the received data and stored information, and displaying the plan on an electronic display. The stored information includes preoperative, intraoperative, and postoperative data from previous patients with similarities to the current patient, aiding in determining the alignment, position, design, or type of implant to be installed during the procedure. The method also involves assessing factors such as joint stiffness, laxity, bone density, and fall risk score to customize the treatment plan accordingly.

Furthermore, the patent describes the use of additional data from a sensored implant installed on the patient during the treatment plan to adjust the alignment, position, design, or type of the implant in a secondary medical treatment plan. The method also involves receiving data from a robotic device post-treatment to further refine the plan based on biometrics, incision length, soft tissue integrity, pressure, and implant position data. By integrating primary and secondary data with stored information, the method aims to enhance the precision and effectiveness of medical treatment plans, particularly in total joint replacement surgeries, by leveraging wearable sensors, implants, and robotic devices to optimize patient outcomes.

To know more about GlobalData’s detailed insights on Stryker, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.